{
    "xml": "<topic id=\"PHP3939\" outputclass=\"drug\" rev=\"1.11\" type=\"drug\" namespace=\"/drugs/chloroquine\" basename=\"chloroquine\" title=\"CHLOROQUINE\">\n<title>CHLOROQUINE</title>\n<body>\r\n<p outputclass=\"interactionsLinks\"> List of individual interactants: <xref format=\"dita\" href=\"#bnf_int_335\" namespace=\"/interactions/list-of-drug-interactions/antimalarials/chloroquine\">Chloroquine</xref>\n</p>\n<data name=\"vtmid\">13590911000001107</data>\r\n<data name=\"vtmid\">13591011000001104</data>\n<data name=\"classifications\">\n<data name=\"classification\">\n<data name=\"drugClassification\">\n<xref format=\"dita\" scope=\"local\" type=\"drugClassification\" href=\"#_589232130\" title=\"4-Aminoquinolines\">4-Aminoquinolines</xref>\n</data>\n</data>\n</data>\n<data name=\"primaryDomainOfEffect\">\n<data name=\"domainOfEffect\">  </data>\n</data>\n<data name=\"secondaryDomainsOfEffect\">\n<data name=\"domainOfEffect\">  </data>\r\n<data name=\"domainOfEffect\">  </data>\n</data>\r\n</body>\n<topic id=\"PHP58442\" outputclass=\"indicationsAndDose\" rev=\"1.51\" parent=\"/drugs/chloroquine\">\n<title>Indications and dose</title>\n<body>\n<section outputclass=\"indicationAndDoseGroup\">\n<sectiondiv outputclass=\"therapeuticIndications\">\n<p outputclass=\"therapeuticIndication\">Active rheumatoid arthritis (administered on expert advice)</p>\n<p outputclass=\"therapeuticIndication\">Systemic and discoid lupus erythematosus (administered on expert advice)</p>\n</sectiondiv>\n<p outputclass=\"routesOfAdministration\">By mouth</p>\n<ul outputclass=\"patientGroups\">\n<li outputclass=\"patientGroup adult\">\n<p>Adult</p>\n<p>150&#8239;mg daily; maximum 2.5&#8239;mg/kg per day.</p>\n</li>\n</ul>\n</section>\n<section outputclass=\"indicationAndDoseGroup\">\n<sectiondiv outputclass=\"therapeuticIndications\">\n<p outputclass=\"therapeuticIndication\">Prophylaxis of malaria</p>\n</sectiondiv>\n<p outputclass=\"routesOfAdministration\">Initially by mouth using syrup</p>\n<ul outputclass=\"patientGroups\">\n<li outputclass=\"patientGroup child\">\n<p>Child 6 weeks&#8211;5 months (body-weight 4.5&#8211;7 kg)</p>\n<p>50&#8239;mg once weekly, started 1 week before entering endemic area and continued for 4 weeks after leaving.</p>\n</li>\n<li outputclass=\"patientGroup child\">\n<p>Child 6&#8211;11 months (body-weight 8&#8211;10 kg)</p>\n<p>75&#8239;mg once weekly, started 1 week before entering endemic area and continued for 4 weeks after leaving.</p>\n</li>\n<li outputclass=\"patientGroup child\">\n<p>Child 1&#8211;2 years (body-weight 11&#8211;14 kg)</p>\n<p>100&#8239;mg once weekly, started 1 week before entering endemic area and continued for 4 weeks after leaving.</p>\n</li>\n<li outputclass=\"patientGroup child\">\n<p>Child 3&#8211;4 years (body-weight 15&#8211;16.4 kg)</p>\n<p>125&#8239;mg once weekly, started 1 week before entering endemic area and continued for 4 weeks after leaving.</p>\n</li>\n<li outputclass=\"patientGroup child\">\n<p>Child 4&#8211;7 years (body-weight 16.5&#8211;24 kg)</p>\n<p>150&#8239;mg once weekly, alternatively (by mouth using tablets) 155&#8239;mg once weekly, started 1 week before entering endemic area and continued for 4 weeks after leaving.</p>\n</li>\n<li outputclass=\"patientGroup child\">\n<p>Child 8&#8211;12 years (body-weight 25&#8211;44 kg)</p>\n<p>225&#8239;mg once weekly, alternatively (by mouth using tablets) 232.5&#8239;mg once weekly, started 1 week before entering endemic area and continued for 4 weeks after leaving.</p>\n</li>\n<li outputclass=\"patientGroup child\">\n<p>Child 13&#8211;17 years (body-weight 45 kg and above)</p>\n<p>310&#8239;mg once weekly, started 1 week before entering endemic area and continued for 4 weeks after leaving.</p>\n</li>\n<li outputclass=\"patientGroup adult\">\n<p>Adult (body-weight 45 kg and above)</p>\n<p>310&#8239;mg once weekly, started 1 week before entering endemic area and continued for 4 weeks after leaving.</p>\n</li>\n</ul>\n</section>\n<section outputclass=\"indicationAndDoseGroup\">\n<sectiondiv outputclass=\"therapeuticIndications\">\n<p outputclass=\"therapeuticIndication\">Treatment of non-falciparum malaria</p>\n</sectiondiv>\n<p outputclass=\"routesOfAdministration\">By mouth</p>\n<ul outputclass=\"patientGroups\">\n<li outputclass=\"patientGroup child\">\n<p>Child</p>\n<p>Initially 10&#8239;mg/kg (max. per dose 620&#8239;mg), then 5&#8239;mg/kg after 6&#8211;8&#8239;hours (max. per dose 310&#8239;mg), then 5&#8239;mg/kg daily (max. per dose 310&#8239;mg) for 2 days.</p>\n</li>\n<li outputclass=\"patientGroup adult\">\n<p>Adult</p>\n<p>Initially 620&#8239;mg, then 310&#8239;mg after 6&#8211;8&#8239;hours, then 310&#8239;mg for 2 days, approximate total cumulative dose of 25 mg/kg of base.</p>\n</li>\n</ul>\n</section>\n<section outputclass=\"indicationAndDoseGroup\">\n<sectiondiv outputclass=\"therapeuticIndications\">\n<p outputclass=\"therapeuticIndication\">\n<ph outputclass=\"organism\">\n<i>P. vivax</i>\n</ph> or <ph outputclass=\"organism\">\n<i>P. ovale</i>\n</ph> infection during pregnancy while radical cure is postponed</p>\n</sectiondiv>\n<p outputclass=\"routesOfAdministration\">By mouth</p>\n<ul outputclass=\"patientGroups\">\n<li outputclass=\"patientGroup adult\">\n<p>Adult</p>\n<p>310&#8239;mg once weekly.</p>\n</li>\n</ul>\n</section>\n<section outputclass=\"extremesOfBodyWeight\">\n<title>Doses at extremes of body-weight</title>\n<p>In active rheumatoid arthritis and systemic and discoid lupus erythematosus, to avoid excessive dosage in obese patients, the daily maximum dose should be calculated on the basis of ideal body weight.</p>\n</section>\n<section outputclass=\"doseEquivalence\">\n<title>Dose equivalence and conversion</title>\n<p>\n<b>Doses expressed as chloroquine base</b>. Chloroquine base 150&#8239;mg = chloroquine sulfate 200&#8239;mg = chloroquine phosphate 250&#8239;mg (approx).</p>\n</section>\n</body>\n</topic>\n<topic id=\"PHP58380\" outputclass=\"unlicensedUse\" rev=\"1.25\" parent=\"/drugs/chloroquine\">\n<title>Unlicensed use</title>\n<body>\n<section>\n<sectiondiv>\n<p>Chloroquine doses for the treatment and prophylaxis of malaria in BNF publications may differ from those in product literature.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP58564\" outputclass=\"importantSafetyInformation\" rev=\"1.21\" parent=\"/drugs/chloroquine\">\n<title>Important safety information</title>\n<body>\n<section>\n<sectiondiv>\n<p outputclass=\"specificity\">In adults</p>\n<p>Ocular toxicity is unlikely if the dose of chloroquine phosphate does not exceed 4&#8239;mg/kg daily (equivalent to chloroquine base approx. 2.5&#8239;mg/kg daily).</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP58648\" outputclass=\"cautions\" rev=\"1.44\" parent=\"/drugs/chloroquine\">\n<title>Cautions</title>\n<body>\r\n<section outputclass=\"cautions\">\r\n<title>General cautions:</title>\r\n<p>\r\n<ph outputclass=\"caution\">\r\n<xref format=\"dita\" href=\"#PHP78608\" type=\"bookmark\" namespace=\"/treatment-summaries/acute-porphyrias\">Acute porphyrias</xref>\r\n</ph>; <ph outputclass=\"caution\">G6PD deficiency</ph>; <ph outputclass=\"caution\">long-term therapy (regular ophthalmic examination recommended by manufacturers)</ph>; <ph outputclass=\"caution\">may aggravate myasthenia gravis</ph>; <ph outputclass=\"caution\">may exacerbate psoriasis</ph>; <ph outputclass=\"caution\">neurological disorders, especially epilepsy (avoid for prophylaxis of malaria if history of epilepsy)</ph>; <ph outputclass=\"caution\">severe gastro-intestinal disorders</ph>\r\n</p>\r\n<sectiondiv outputclass=\"additionalCautions\">\r\n<p outputclass=\"title\">Specific cautions:</p>\r\n<sectiondiv outputclass=\"cautionsOrContraindicationsWithRoutes\">\r\n<p outputclass=\"title\">With oral use</p>\r\n<p>\r\n<ph outputclass=\"caution\">elderly</ph> (in adults)</p>\n</sectiondiv>\n</sectiondiv>\n</section>\r\n<section outputclass=\"importantAdvice\">\r\n<title>Cautions, further information</title>\r\n<sectiondiv>\r\n<p outputclass=\"specificity\">With <ph outputclass=\"route\">oral</ph> use in adults</p>\r\n<p outputclass=\"title\">Screening for ocular toxicity</p>\r\n<p>A review group convened by the Royal College of Ophthalmologists has updated guidelines for screening to prevent ocular toxicity on long-term treatment with chloroquine and hydroxychloroquine (<i>Hydroxychloroquine and Ocular Toxicity: Recommendations on Screening 2009</i>). Chloroquine should be considered (for treating chronic inflammatory conditions) <b>only</b> if other drugs have failed. All patients taking chloroquine should receive ocular examination according to a protocol arranged locally between the prescriber and the ophthalmologist.</p>\n</sectiondiv>\n</section>\r\n\r\n\r\n\r\n\r\n\r\n</body>\n</topic>\n<topic id=\"PHP58430\" outputclass=\"interactions\" rev=\"1.15\" parent=\"/drugs/chloroquine\">\n<title>Interactions</title>\n<body>\n<section outputclass=\"general\">\n<sectiondiv>\n<p>Avoid concurrent therapy with hepatotoxic drugs.</p>\n<p>Appendix 1 (chloroquine, hydroxychloroquine).</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP58392\" outputclass=\"sideEffects\" rev=\"1.53\" parent=\"/drugs/chloroquine\">\n<title>Side-effects</title>\n<body>\n<section outputclass=\"generalSideEffects\">\n<title>General side-effects:</title>\n<sectiondiv outputclass=\"frequencies\">\n<sectiondiv outputclass=\"commonOrVeryCommon\">\n<p outputclass=\"title\">Common or very common</p>\n<p outputclass=\"sideEffects\">\n<ph outputclass=\"sideEffect\">Gastro-intestinal disturbances</ph>; <ph outputclass=\"sideEffect\">headache</ph>; <ph outputclass=\"sideEffect\">pruritus</ph>; <ph outputclass=\"sideEffect\">rashes</ph>; <ph outputclass=\"sideEffect\">skin reactions</ph>\n</p>\n</sectiondiv>\n<sectiondiv outputclass=\"uncommon\">\n<p outputclass=\"title\">Uncommon</p>\n<p outputclass=\"sideEffects\">\n<ph outputclass=\"sideEffect\">Convulsions</ph>; <ph outputclass=\"sideEffect\">discoloration of mucous membranes</ph>; <ph outputclass=\"sideEffect\">discoloration of nails</ph>; <ph outputclass=\"sideEffect\">discoloration of skin</ph>; <ph outputclass=\"sideEffect\">ECG changes</ph>; <ph outputclass=\"sideEffect\">hair depigmentation</ph>; <ph outputclass=\"sideEffect\">hair loss</ph>; <ph outputclass=\"sideEffect\">keratopathy</ph>; <ph outputclass=\"sideEffect\">ototoxicity</ph>; <ph outputclass=\"sideEffect\">retinal damage</ph>; <ph outputclass=\"sideEffect\">visual changes</ph>\n</p>\n</sectiondiv>\n<sectiondiv outputclass=\"rare\">\n<p outputclass=\"title\">Rare</p>\n<p outputclass=\"sideEffects\">\n<ph outputclass=\"sideEffect\">Acute generalised exanthematous pustulosis</ph>; <ph outputclass=\"sideEffect\">agranulocytosis</ph>; <ph outputclass=\"sideEffect\">angioedema</ph>; <ph outputclass=\"sideEffect\">aplastic anaemia</ph>; <ph outputclass=\"sideEffect\">blood disorders</ph>; <ph outputclass=\"sideEffect\">bone marrow suppression</ph>; <ph outputclass=\"sideEffect\">cardiomyopathy</ph>; <ph outputclass=\"sideEffect\">emotional disturbances</ph>; <ph outputclass=\"sideEffect\">exfoliative dermatitis</ph>; <ph outputclass=\"sideEffect\">hepatic damage</ph>; <ph outputclass=\"sideEffect\">hypersensitivity reactions</ph>; <ph outputclass=\"sideEffect\">mental changes</ph>; <ph outputclass=\"sideEffect\">myopathy</ph>; <ph outputclass=\"sideEffect\">neuromyopathy</ph>; <ph outputclass=\"sideEffect\">photosensitivity</ph>; <ph outputclass=\"sideEffect\">psychosis</ph>; <ph outputclass=\"sideEffect\">Stevens-Johnson syndrome</ph>; <ph outputclass=\"sideEffect\">thrombocytopenia</ph>; <ph outputclass=\"sideEffect\">urticaria</ph>\n</p>\n</sectiondiv>\n<sectiondiv outputclass=\"notKnown\">\n<p outputclass=\"title\">Frequency not known</p>\n<p outputclass=\"sideEffects\">\n<ph outputclass=\"sideEffect\">Diffuse parenchymal lung disease</ph>; <ph outputclass=\"sideEffect\">drug rash with eosinophilia and systemic symptoms</ph>; <ph outputclass=\"sideEffect\">extrapyramidal symptoms (associated with use in malaria)</ph>; <ph outputclass=\"sideEffect\">hypotension</ph>; <ph outputclass=\"sideEffect\">visual disturbances</ph>\n</p>\n</sectiondiv>\n</sectiondiv>\n</section>\n<section outputclass=\"specificSideEffects\">\n<title>Specific side-effects:</title>\n<sectiondiv outputclass=\"frequencies\">\n<sectiondiv outputclass=\"notKnown\">\n<p outputclass=\"title\">Frequency not known</p>\n<sectiondiv outputclass=\"sideEffectsWithRoutes\">\n<p outputclass=\"title\">With oral use</p>\n<p>\n<ph outputclass=\"sideEffect\">bronchospasm</ph> (in children)</p>\n</sectiondiv>\n</sectiondiv>\n</sectiondiv>\n</section>\n<section outputclass=\"sideEffectsAdvice\">\n<title>Side-effects, further information</title>\n<sectiondiv>\n<p outputclass=\"title\">Malaria prophylaxis and treatment</p>\n<p>Serious skin reactions, ECG changes, visual effects, ototoxicity, blood disorders, mental changes, myopathies and hepatic damage are not usually associated with malaria prophylaxis or treatment.</p>\n</sectiondiv>\n</section>\n<section outputclass=\"sideEffectsOverdosageInformation\">\n<title>Overdose</title>\n<sectiondiv>\n<p>Chlorquine is very toxic in overdosage; overdosage is extremely hazardous and difficult to treat. Urgent advice from the National Poisons Information Service is essential. Life-threatening features include arrhythmias (which can have a very rapid onset) and convulsions (which can be intractable).</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP58424\" outputclass=\"pregnancy\" parent=\"/drugs/chloroquine\">\n<title>Pregnancy</title>\n<body>\n<section outputclass=\"generalInformation\">\n<sectiondiv>\n<p>Benefit of use in prophylaxis and treatment in malaria outweighs risk. For rheumatoid disease, it is not necessary to withdraw an antimalarial drug during pregnancy if the disease is well controlled.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP58685\" outputclass=\"breastFeeding\" parent=\"/drugs/chloroquine\">\n<title>Breast feeding</title>\n<body>\n<section outputclass=\"generalInformation\">\n<sectiondiv>\n<p>Present in breast milk and breast-feeding should be avoided when used to treat rheumatic disease. Amount in milk probably too small to be harmful when used for malaria.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP58464\" outputclass=\"hepaticImpairment\" parent=\"/drugs/chloroquine\">\n<title>Hepatic impairment</title>\n<body>\n<section outputclass=\"generalInformation\">\n<sectiondiv>\n<p>Use with caution in moderate to severe impairment.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP58414\" outputclass=\"renalImpairment\" parent=\"/drugs/chloroquine\">\n<title>Renal impairment</title>\n<body>\n<section outputclass=\"doseAdjustments\">\n<sectiondiv>\n<p>Only partially excreted by the kidneys and reduction of the dose is not required for prophylaxis of malaria except in severe impairment.</p>\n<p>For rheumatoid arthritis and lupus erythematosus, reduce dose. </p>\n</sectiondiv>\n</section>\n<section outputclass=\"generalInformation\">\n<sectiondiv>\n<p>Manufacturers advise caution.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP58374\" outputclass=\"monitoringRequirements\" parent=\"/drugs/chloroquine\">\n<title>Monitoring requirements</title>\n<body>\n<section outputclass=\"monitoringOfPatientParameters\">\n<sectiondiv>\n<p outputclass=\"specificity\">With <ph outputclass=\"route\">oral</ph> use in adults</p>\n<p>Manufacturers recommend regular ophthalmological examination but the evidence of practical value is unsatisfactory.</p>\n</sectiondiv>\n<sectiondiv>\n<p outputclass=\"specificity\">With <ph outputclass=\"route\">oral</ph> use in children</p>\n<p>Ophthalmic examination with long-term therapy.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP58419\" outputclass=\"patientAndCarerAdvice\" rev=\"1.21\" parent=\"/drugs/chloroquine\">\n<title>Patient and carer advice</title>\n<body>\n<section outputclass=\"generalPatientAdvice\">\n<sectiondiv>\n<p>Warn travellers going to malarious areas about <b>importance</b> of avoiding mosquito bites, <b>importance</b> of taking prophylaxis regularly, and <b>importance</b> of immediate visit to doctor if ill within 1 year and <b>especially</b> within 3 months of return.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP58363\" outputclass=\"nationalFunding\" rev=\"1.24\" parent=\"/drugs/chloroquine\">\n<title>National funding/access decisions</title>\n<body>\n<section outputclass=\"nonNHS\">\n<title>NHS restrictions</title>\n<sectiondiv>\n<p>Drugs for malaria prophylaxis not prescribable on the NHS; health authorities may investigate circumstances under which antimalarials are prescribed.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP58351\" outputclass=\"exceptionsToLegalCategory\" rev=\"1.19\" parent=\"/drugs/chloroquine\">\n<title>Exceptions to legal category</title>\n<body>\n<section>\n<sectiondiv>\n<p>Can be sold to the public provided it is licensed and labelled for the prophylaxis of malaria.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP3939-medicinalForms\" outputclass=\"medicinalForms\" parent=\"/drugs/chloroquine\">\n<title>Medicinal forms</title>\n<body>\n<section outputclass=\"licensingVariationStatement\">\n<p>There can be variation in the licensing of different medicines containing the same drug.</p>\n</section>\n</body>\n</topic>\n<parents>\n<xref format=\"dita\" scope=\"local\" type=\"drugs\" href=\"#drugs\" title=\"Drugs\" namespace=\"/drugs\">Drugs</xref>\n</parents>\n<children>\n<xref format=\"dita\" scope=\"local\" type=\"medicinalForm\" href=\"#PHP76546\" title=\"Tablet\" namespace=\"/drugs/chloroquine/tablet\">Tablet</xref>\n<xref format=\"dita\" scope=\"local\" type=\"medicinalForm\" href=\"#PHP76551\" title=\"Oral solution\" namespace=\"/drugs/chloroquine/oral-solution\">Oral solution</xref>\n</children>\n<backlinks>\n<xref format=\"dita\" scope=\"local\" type=\"drug\" href=\"#PHP98624\" namespace=\"/drugs/chloroquine-with-proguanil\" title=\"CHLOROQUINE WITH PROGUANIL\" count=\"1\" rel=\"backlink\">CHLOROQUINE WITH PROGUANIL</xref>\n<xref format=\"dita\" scope=\"local\" type=\"drugClassifications\" href=\"#PHP106980\" namespace=\"/drug-classifications\" title=\"Drug classifications\" count=\"1\" rel=\"backlink\">Drug classifications</xref>\n<xref format=\"dita\" scope=\"local\" type=\"treatmentSummary\" href=\"#PHP97237\" namespace=\"/guidance/adverse-reactions-to-drugs\" title=\"Adverse reactions to drugs\" count=\"1\" rel=\"backlink\">Adverse reactions to drugs</xref>\n<xref format=\"dita\" scope=\"local\" type=\"treatmentSummary\" href=\"#PHP78098\" namespace=\"/treatment-summaries/antimalarials\" title=\"Antimalarials\" count=\"2\" rel=\"backlink\">Antimalarials</xref>\n<xref format=\"dita\" scope=\"local\" type=\"treatmentSummary\" href=\"#PHP78102\" namespace=\"/treatment-summaries/malaria-prophylaxis\" title=\"Malaria, prophylaxis\" count=\"4\" rel=\"backlink\">Malaria, prophylaxis</xref>\n<xref format=\"dita\" scope=\"local\" type=\"treatmentSummary\" href=\"#PHP78113\" namespace=\"/treatment-summaries/malaria-treatment\" title=\"Malaria, treatment\" count=\"7\" rel=\"backlink\">Malaria, treatment</xref>\n<xref format=\"dita\" scope=\"local\" type=\"treatmentSummary\" href=\"#PHP78421\" namespace=\"/treatment-summaries/rheumatic-disease-suppressing-drugs\" title=\"Rheumatic disease, suppressing drugs\" count=\"5\" rel=\"backlink\">Rheumatic disease, suppressing drugs</xref>\n<xref format=\"dita\" scope=\"local\" type=\"treatmentSummary\" href=\"#PHP78455\" namespace=\"/treatment-summaries/corticosteroids-inflammatory-disorders\" title=\"Corticosteroids, inflammatory disorders\" count=\"1\" rel=\"backlink\">Corticosteroids, inflammatory disorders</xref>\n<xref format=\"dita\" scope=\"local\" type=\"treatmentSummary\" href=\"#PHP78614\" namespace=\"/treatment-summaries/arthritis\" title=\"Arthritis\" count=\"1\" rel=\"backlink\">Arthritis</xref>\n</backlinks>\n<links>\n<xref format=\"dita\" scope=\"local\" type=\"interaction\" href=\"#bnf_int_335\" namespace=\"/interactions/list-of-drug-interactions/antimalarials/chloroquine\" title=\"Chloroquine\" count=\"1\" rel=\"link\">Chloroquine</xref>\n<xref format=\"dita\" scope=\"local\" type=\"treatmentSummary\" href=\"#PHP78608\" namespace=\"/treatment-summaries/acute-porphyrias\" title=\"Acute porphyrias\" count=\"1\" rel=\"link\">Acute porphyrias</xref>\n<xref format=\"dita\" scope=\"local\" type=\"#drugs\" href=\"#drugs\" namespace=\"/drugs\" title=\"Drugs\" count=\"1\" rel=\"link\">Drugs</xref>\n<xref format=\"dita\" scope=\"local\" type=\"medicinalForm\" href=\"#PHP76546\" namespace=\"/drugs/chloroquine/tablet\" title=\"Tablet\" count=\"1\" rel=\"link\">Tablet</xref>\n<xref format=\"dita\" scope=\"local\" type=\"medicinalForm\" href=\"#PHP76551\" namespace=\"/drugs/chloroquine/oral-solution\" title=\"Oral solution\" count=\"1\" rel=\"link\">Oral solution</xref>\n</links>\n</topic>",
    "id": "PHP3939",
    "outputclass": "drug",
    "rev": "1.11",
    "type": "drug",
    "namespace": "/drugs/chloroquine",
    "basename": "chloroquine",
    "title": "CHLOROQUINE",
    "interactants": [
        {
            "id": "bnf_int_335",
            "label": "Chloroquine"
        }
    ],
    "vtmid": "13591011000001104",
    "drugClassification": [
        "4-Aminoquinolines"
    ],
    "primaryDomainOfEffect": {
        "": {
            "domain": "",
            "therapeuticUses": {}
        }
    },
    "secondaryDomainsOfEffect": {
        "": {
            "domain": "",
            "therapeuticUses": {}
        }
    },
    "indicationsAndDoses": {
        "indicationAndDoseGroups": [
            {
                "indications": [
                    {
                        "textContent": "Active rheumatoid arthritis (administered on expert advice)",
                        "html": "Active rheumatoid arthritis (administered on expert advice)"
                    },
                    {
                        "textContent": "Systemic and discoid lupus erythematosus (administered on expert advice)",
                        "html": "Systemic and discoid lupus erythematosus (administered on expert advice)"
                    }
                ],
                "specificity": {
                    "routes": [
                        "mouth"
                    ],
                    "textContent": "By mouth",
                    "html": "By mouth"
                },
                "adult": [
                    {
                        "textContent": "150 mg daily; maximum 2.5 mg/kg per day.",
                        "html": "<p>150&#8239;mg daily; maximum 2.5&#8239;mg/kg per day.</p>"
                    }
                ]
            },
            {
                "indications": [
                    {
                        "textContent": "Prophylaxis of malaria",
                        "html": "Prophylaxis of malaria"
                    }
                ],
                "specificity": {
                    "routes": [
                        "Initially mouth using syrup"
                    ],
                    "textContent": "Initially by mouth using syrup",
                    "html": "Initially by mouth using syrup"
                },
                "child": [
                    {
                        "textContent": "50 mg once weekly, started 1 week before entering endemic area and continued for 4 weeks after leaving.",
                        "html": "<p>50&#8239;mg once weekly, started 1 week before entering endemic area and continued for 4 weeks after leaving.</p>",
                        "ageGroup": "6 weeks&#8211;5 months (body-weight 4.5&#8211;7 kg)"
                    },
                    {
                        "textContent": "75 mg once weekly, started 1 week before entering endemic area and continued for 4 weeks after leaving.",
                        "html": "<p>75&#8239;mg once weekly, started 1 week before entering endemic area and continued for 4 weeks after leaving.</p>",
                        "ageGroup": "6&#8211;11 months (body-weight 8&#8211;10 kg)"
                    },
                    {
                        "textContent": "100 mg once weekly, started 1 week before entering endemic area and continued for 4 weeks after leaving.",
                        "html": "<p>100&#8239;mg once weekly, started 1 week before entering endemic area and continued for 4 weeks after leaving.</p>",
                        "ageGroup": "1&#8211;2 years (body-weight 11&#8211;14 kg)"
                    },
                    {
                        "textContent": "125 mg once weekly, started 1 week before entering endemic area and continued for 4 weeks after leaving.",
                        "html": "<p>125&#8239;mg once weekly, started 1 week before entering endemic area and continued for 4 weeks after leaving.</p>",
                        "ageGroup": "3&#8211;4 years (body-weight 15&#8211;16.4 kg)"
                    },
                    {
                        "textContent": "150 mg once weekly, alternatively (by mouth using tablets) 155 mg once weekly, started 1 week before entering endemic area and continued for 4 weeks after leaving.",
                        "html": "<p>150&#8239;mg once weekly, alternatively (by mouth using tablets) 155&#8239;mg once weekly, started 1 week before entering endemic area and continued for 4 weeks after leaving.</p>",
                        "ageGroup": "4&#8211;7 years (body-weight 16.5&#8211;24 kg)"
                    },
                    {
                        "textContent": "225 mg once weekly, alternatively (by mouth using tablets) 232.5 mg once weekly, started 1 week before entering endemic area and continued for 4 weeks after leaving.",
                        "html": "<p>225&#8239;mg once weekly, alternatively (by mouth using tablets) 232.5&#8239;mg once weekly, started 1 week before entering endemic area and continued for 4 weeks after leaving.</p>",
                        "ageGroup": "8&#8211;12 years (body-weight 25&#8211;44 kg)"
                    },
                    {
                        "textContent": "310 mg once weekly, started 1 week before entering endemic area and continued for 4 weeks after leaving.",
                        "html": "<p>310&#8239;mg once weekly, started 1 week before entering endemic area and continued for 4 weeks after leaving.</p>",
                        "ageGroup": "13&#8211;17 years (body-weight 45 kg and above)"
                    }
                ],
                "adult": [
                    {
                        "textContent": "310 mg once weekly, started 1 week before entering endemic area and continued for 4 weeks after leaving.",
                        "html": "<p>310&#8239;mg once weekly, started 1 week before entering endemic area and continued for 4 weeks after leaving.</p>",
                        "ageGroup": "(body-weight 45 kg and above)"
                    }
                ]
            },
            {
                "indications": [
                    {
                        "textContent": "Treatment of non-falciparum malaria",
                        "html": "Treatment of non-falciparum malaria"
                    }
                ],
                "specificity": {
                    "routes": [
                        "mouth"
                    ],
                    "textContent": "By mouth",
                    "html": "By mouth"
                },
                "child": [
                    {
                        "textContent": "Initially 10 mg/kg (max. per dose 620 mg), then 5 mg/kg after 6&#8211;8 hours (max. per dose 310 mg), then 5 mg/kg daily (max. per dose 310 mg) for 2 days.",
                        "html": "<p>Initially 10&#8239;mg/kg (max. per dose 620&#8239;mg), then 5&#8239;mg/kg after 6&#8211;8&#8239;hours (max. per dose 310&#8239;mg), then 5&#8239;mg/kg daily (max. per dose 310&#8239;mg) for 2 days.</p>"
                    }
                ],
                "adult": [
                    {
                        "textContent": "Initially 620 mg, then 310 mg after 6&#8211;8 hours, then 310 mg for 2 days, approximate total cumulative dose of 25 mg/kg of base.",
                        "html": "<p>Initially 620&#8239;mg, then 310&#8239;mg after 6&#8211;8&#8239;hours, then 310&#8239;mg for 2 days, approximate total cumulative dose of 25 mg/kg of base.</p>"
                    }
                ]
            },
            {
                "indications": [
                    {
                        "textContent": "P. vivax or P. ovale infection during pregnancy while radical cure is postponed",
                        "html": "<ph outputclass=\"organism\"> <i>P. vivax</i> </ph> or <ph outputclass=\"organism\"> <i>P. ovale</i> </ph> infection during pregnancy while radical cure is postponed",
                        "organism": "P. ovale"
                    }
                ],
                "specificity": {
                    "routes": [
                        "mouth"
                    ],
                    "textContent": "By mouth",
                    "html": "By mouth",
                    "organism": "P. ovale"
                },
                "adult": [
                    {
                        "textContent": "310 mg once weekly.",
                        "html": "<p>310&#8239;mg once weekly.</p>"
                    }
                ]
            }
        ],
        "extremesOfBodyWeight": [
            {
                "type": "extremesOfBodyWeight",
                "title": "Doses at extremes of body-weight",
                "textContent": "In active rheumatoid arthritis and systemic and discoid lupus erythematosus, to avoid excessive dosage in obese patients, the daily maximum dose should be calculated on the basis of ideal body weight.",
                "html": "<p>In active rheumatoid arthritis and systemic and discoid lupus erythematosus, to avoid excessive dosage in obese patients, the daily maximum dose should be calculated on the basis of ideal body weight.</p>"
            }
        ],
        "doseEquivalence": [
            {
                "type": "doseEquivalence",
                "title": "Dose equivalence and conversion",
                "textContent": "Doses expressed as chloroquine base. Chloroquine base 150 mg = chloroquine sulfate 200 mg = chloroquine phosphate 250 mg (approx).",
                "html": "<p>\n<b>Doses expressed as chloroquine base</b>. Chloroquine base 150&#8239;mg = chloroquine sulfate 200&#8239;mg = chloroquine phosphate 250&#8239;mg (approx).</p>"
            }
        ]
    },
    "unlicensedUse": {
        "unlicensedUse": [
            {
                "type": "unlicensedUse",
                "textContent": "Chloroquine doses for the treatment and prophylaxis of malaria in BNF publications may differ from those in product literature.",
                "html": "<p>Chloroquine doses for the treatment and prophylaxis of malaria in BNF publications may differ from those in product literature.</p>"
            }
        ]
    },
    "importantSafetyInformation": {
        "importantSafetyInformation": [
            {
                "type": "importantSafetyInformation",
                "specificity": {
                    "textContent": "In adults",
                    "html": "In adults",
                    "patientType": "adults"
                },
                "textContent": "Ocular toxicity is unlikely if the dose of chloroquine phosphate does not exceed 4 mg/kg daily (equivalent to chloroquine base approx. 2.5 mg/kg daily).",
                "html": "<p>Ocular toxicity is unlikely if the dose of chloroquine phosphate does not exceed 4&#8239;mg/kg daily (equivalent to chloroquine base approx. 2.5&#8239;mg/kg daily).</p>"
            }
        ]
    },
    "cautions": {
        "cautions": [
            {
                "type": "cautions",
                "textContent": "Acute porphyrias",
                "html": "<xref format=\"dita\" href=\"#PHP78608\" type=\"bookmark\" namespace=\"/treatment-summaries/acute-porphyrias\">Acute porphyrias</xref>",
                "references": [
                    {
                        "id": "PHP78608",
                        "label": "Acute porphyrias"
                    }
                ]
            },
            {
                "type": "cautions",
                "textContent": "G6PD deficiency",
                "html": "G6PD deficiency"
            },
            {
                "type": "cautions",
                "textContent": "long-term therapy (regular ophthalmic examination recommended by manufacturers)",
                "html": "long-term therapy (regular ophthalmic examination recommended by manufacturers)"
            },
            {
                "type": "cautions",
                "textContent": "may aggravate myasthenia gravis",
                "html": "may aggravate myasthenia gravis"
            },
            {
                "type": "cautions",
                "textContent": "may exacerbate psoriasis",
                "html": "may exacerbate psoriasis"
            },
            {
                "type": "cautions",
                "textContent": "neurological disorders, especially epilepsy (avoid for prophylaxis of malaria if history of epilepsy)",
                "html": "neurological disorders, especially epilepsy (avoid for prophylaxis of malaria if history of epilepsy)"
            },
            {
                "type": "cautions",
                "textContent": "severe gastro-intestinal disorders",
                "html": "severe gastro-intestinal disorders"
            }
        ],
        "cautionsOrContraindicationsWithRoutes": [
            {
                "type": "cautionsOrContraindicationsWithRoutes",
                "textContent": "elderly in adults",
                "html": "elderly in adults",
                "specificity": {
                    "textContent": "With oral use",
                    "html": "With oral use",
                    "routes": [
                        "oral"
                    ],
                    "patientType": "adults"
                }
            }
        ],
        "importantAdvice": [
            {
                "type": "importantAdvice",
                "specificity": {
                    "textContent": "With oral use in adults",
                    "html": "With <ph outputclass=\"route\">oral</ph> use in adults",
                    "patientType": "adults",
                    "routes": [
                        "oral"
                    ]
                },
                "title": "Screening for ocular toxicity",
                "textContent": "A review group convened by the Royal College of Ophthalmologists has updated guidelines for screening to prevent ocular toxicity on long-term treatment with chloroquine and hydroxychloroquine (Hydroxychloroquine and Ocular Toxicity: Recommendations on Screening 2009). Chloroquine should be considered (for treating chronic inflammatory conditions) only if other drugs have failed. All patients taking chloroquine should receive ocular examination according to a protocol arranged locally between the prescriber and the ophthalmologist.",
                "html": "<p>A review group convened by the Royal College of Ophthalmologists has updated guidelines for screening to prevent ocular toxicity on long-term treatment with chloroquine and hydroxychloroquine (<i>Hydroxychloroquine and Ocular Toxicity: Recommendations on Screening 2009</i>). Chloroquine should be considered (for treating chronic inflammatory conditions) <b>only</b> if other drugs have failed. All patients taking chloroquine should receive ocular examination according to a protocol arranged locally between the prescriber and the ophthalmologist.</p>"
            }
        ]
    },
    "interactions": {
        "general": [
            {
                "type": "general",
                "textContent": "Avoid concurrent therapy with hepatotoxic drugs.\n\nAppendix 1 (chloroquine, hydroxychloroquine).",
                "html": "<p>Avoid concurrent therapy with hepatotoxic drugs.</p><p>Appendix 1 (chloroquine, hydroxychloroquine).</p>"
            }
        ]
    },
    "sideEffects": {
        "general": {
            "frequencies": {
                "commonOrVeryCommon": [
                    {
                        "type": "commonOrVeryCommon",
                        "textContent": "Gastro-intestinal disturbances",
                        "html": "Gastro-intestinal disturbances",
                        "frequency": "commonOrVeryCommon",
                        "specificity": {
                            "textContent": "Common or very common",
                            "html": "Common or very common"
                        }
                    },
                    {
                        "type": "commonOrVeryCommon",
                        "textContent": "headache",
                        "html": "headache",
                        "frequency": "commonOrVeryCommon",
                        "specificity": {
                            "textContent": "Common or very common",
                            "html": "Common or very common"
                        }
                    },
                    {
                        "type": "commonOrVeryCommon",
                        "textContent": "pruritus",
                        "html": "pruritus",
                        "frequency": "commonOrVeryCommon",
                        "specificity": {
                            "textContent": "Common or very common",
                            "html": "Common or very common"
                        }
                    },
                    {
                        "type": "commonOrVeryCommon",
                        "textContent": "rashes",
                        "html": "rashes",
                        "frequency": "commonOrVeryCommon",
                        "specificity": {
                            "textContent": "Common or very common",
                            "html": "Common or very common"
                        }
                    },
                    {
                        "type": "commonOrVeryCommon",
                        "textContent": "skin reactions",
                        "html": "skin reactions",
                        "frequency": "commonOrVeryCommon",
                        "specificity": {
                            "textContent": "Common or very common",
                            "html": "Common or very common"
                        }
                    }
                ],
                "uncommon": [
                    {
                        "type": "uncommon",
                        "textContent": "Convulsions",
                        "html": "Convulsions",
                        "frequency": "uncommon",
                        "specificity": {
                            "textContent": "Uncommon",
                            "html": "Uncommon"
                        }
                    },
                    {
                        "type": "uncommon",
                        "textContent": "discoloration of mucous membranes",
                        "html": "discoloration of mucous membranes",
                        "frequency": "uncommon",
                        "specificity": {
                            "textContent": "Uncommon",
                            "html": "Uncommon"
                        }
                    },
                    {
                        "type": "uncommon",
                        "textContent": "discoloration of nails",
                        "html": "discoloration of nails",
                        "frequency": "uncommon",
                        "specificity": {
                            "textContent": "Uncommon",
                            "html": "Uncommon"
                        }
                    },
                    {
                        "type": "uncommon",
                        "textContent": "discoloration of skin",
                        "html": "discoloration of skin",
                        "frequency": "uncommon",
                        "specificity": {
                            "textContent": "Uncommon",
                            "html": "Uncommon"
                        }
                    },
                    {
                        "type": "uncommon",
                        "textContent": "ECG changes",
                        "html": "ECG changes",
                        "frequency": "uncommon",
                        "specificity": {
                            "textContent": "Uncommon",
                            "html": "Uncommon"
                        }
                    },
                    {
                        "type": "uncommon",
                        "textContent": "hair depigmentation",
                        "html": "hair depigmentation",
                        "frequency": "uncommon",
                        "specificity": {
                            "textContent": "Uncommon",
                            "html": "Uncommon"
                        }
                    },
                    {
                        "type": "uncommon",
                        "textContent": "hair loss",
                        "html": "hair loss",
                        "frequency": "uncommon",
                        "specificity": {
                            "textContent": "Uncommon",
                            "html": "Uncommon"
                        }
                    },
                    {
                        "type": "uncommon",
                        "textContent": "keratopathy",
                        "html": "keratopathy",
                        "frequency": "uncommon",
                        "specificity": {
                            "textContent": "Uncommon",
                            "html": "Uncommon"
                        }
                    },
                    {
                        "type": "uncommon",
                        "textContent": "ototoxicity",
                        "html": "ototoxicity",
                        "frequency": "uncommon",
                        "specificity": {
                            "textContent": "Uncommon",
                            "html": "Uncommon"
                        }
                    },
                    {
                        "type": "uncommon",
                        "textContent": "retinal damage",
                        "html": "retinal damage",
                        "frequency": "uncommon",
                        "specificity": {
                            "textContent": "Uncommon",
                            "html": "Uncommon"
                        }
                    },
                    {
                        "type": "uncommon",
                        "textContent": "visual changes",
                        "html": "visual changes",
                        "frequency": "uncommon",
                        "specificity": {
                            "textContent": "Uncommon",
                            "html": "Uncommon"
                        }
                    }
                ],
                "rare": [
                    {
                        "type": "rare",
                        "textContent": "Acute generalised exanthematous pustulosis",
                        "html": "Acute generalised exanthematous pustulosis",
                        "frequency": "rare",
                        "specificity": {
                            "textContent": "Rare",
                            "html": "Rare"
                        }
                    },
                    {
                        "type": "rare",
                        "textContent": "agranulocytosis",
                        "html": "agranulocytosis",
                        "frequency": "rare",
                        "specificity": {
                            "textContent": "Rare",
                            "html": "Rare"
                        }
                    },
                    {
                        "type": "rare",
                        "textContent": "angioedema",
                        "html": "angioedema",
                        "frequency": "rare",
                        "specificity": {
                            "textContent": "Rare",
                            "html": "Rare"
                        }
                    },
                    {
                        "type": "rare",
                        "textContent": "aplastic anaemia",
                        "html": "aplastic anaemia",
                        "frequency": "rare",
                        "specificity": {
                            "textContent": "Rare",
                            "html": "Rare"
                        }
                    },
                    {
                        "type": "rare",
                        "textContent": "blood disorders",
                        "html": "blood disorders",
                        "frequency": "rare",
                        "specificity": {
                            "textContent": "Rare",
                            "html": "Rare"
                        }
                    },
                    {
                        "type": "rare",
                        "textContent": "bone marrow suppression",
                        "html": "bone marrow suppression",
                        "frequency": "rare",
                        "specificity": {
                            "textContent": "Rare",
                            "html": "Rare"
                        }
                    },
                    {
                        "type": "rare",
                        "textContent": "cardiomyopathy",
                        "html": "cardiomyopathy",
                        "frequency": "rare",
                        "specificity": {
                            "textContent": "Rare",
                            "html": "Rare"
                        }
                    },
                    {
                        "type": "rare",
                        "textContent": "emotional disturbances",
                        "html": "emotional disturbances",
                        "frequency": "rare",
                        "specificity": {
                            "textContent": "Rare",
                            "html": "Rare"
                        }
                    },
                    {
                        "type": "rare",
                        "textContent": "exfoliative dermatitis",
                        "html": "exfoliative dermatitis",
                        "frequency": "rare",
                        "specificity": {
                            "textContent": "Rare",
                            "html": "Rare"
                        }
                    },
                    {
                        "type": "rare",
                        "textContent": "hepatic damage",
                        "html": "hepatic damage",
                        "frequency": "rare",
                        "specificity": {
                            "textContent": "Rare",
                            "html": "Rare"
                        }
                    },
                    {
                        "type": "rare",
                        "textContent": "hypersensitivity reactions",
                        "html": "hypersensitivity reactions",
                        "frequency": "rare",
                        "specificity": {
                            "textContent": "Rare",
                            "html": "Rare"
                        }
                    },
                    {
                        "type": "rare",
                        "textContent": "mental changes",
                        "html": "mental changes",
                        "frequency": "rare",
                        "specificity": {
                            "textContent": "Rare",
                            "html": "Rare"
                        }
                    },
                    {
                        "type": "rare",
                        "textContent": "myopathy",
                        "html": "myopathy",
                        "frequency": "rare",
                        "specificity": {
                            "textContent": "Rare",
                            "html": "Rare"
                        }
                    },
                    {
                        "type": "rare",
                        "textContent": "neuromyopathy",
                        "html": "neuromyopathy",
                        "frequency": "rare",
                        "specificity": {
                            "textContent": "Rare",
                            "html": "Rare"
                        }
                    },
                    {
                        "type": "rare",
                        "textContent": "photosensitivity",
                        "html": "photosensitivity",
                        "frequency": "rare",
                        "specificity": {
                            "textContent": "Rare",
                            "html": "Rare"
                        }
                    },
                    {
                        "type": "rare",
                        "textContent": "psychosis",
                        "html": "psychosis",
                        "frequency": "rare",
                        "specificity": {
                            "textContent": "Rare",
                            "html": "Rare"
                        }
                    },
                    {
                        "type": "rare",
                        "textContent": "Stevens-Johnson syndrome",
                        "html": "Stevens-Johnson syndrome",
                        "frequency": "rare",
                        "specificity": {
                            "textContent": "Rare",
                            "html": "Rare"
                        }
                    },
                    {
                        "type": "rare",
                        "textContent": "thrombocytopenia",
                        "html": "thrombocytopenia",
                        "frequency": "rare",
                        "specificity": {
                            "textContent": "Rare",
                            "html": "Rare"
                        }
                    },
                    {
                        "type": "rare",
                        "textContent": "urticaria",
                        "html": "urticaria",
                        "frequency": "rare",
                        "specificity": {
                            "textContent": "Rare",
                            "html": "Rare"
                        }
                    }
                ],
                "notKnown": [
                    {
                        "type": "notKnown",
                        "textContent": "Diffuse parenchymal lung disease",
                        "html": "Diffuse parenchymal lung disease",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "drug rash with eosinophilia and systemic symptoms",
                        "html": "drug rash with eosinophilia and systemic symptoms",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "extrapyramidal symptoms (associated with use in malaria)",
                        "html": "extrapyramidal symptoms (associated with use in malaria)",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "hypotension",
                        "html": "hypotension",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "visual disturbances",
                        "html": "visual disturbances",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    }
                ]
            }
        },
        "specific": {
            "frequencies": {
                "notKnown": [
                    {
                        "type": "sideEffectsWithRoutes",
                        "textContent": "bronchospasm in children",
                        "html": "bronchospasm in children",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "With oral use",
                            "html": "With oral use",
                            "routes": [
                                "oral"
                            ],
                            "patientType": "children"
                        }
                    }
                ]
            }
        },
        "advice": [
            {
                "type": "advice",
                "title": "Malaria prophylaxis and treatment",
                "textContent": "Serious skin reactions, ECG changes, visual effects, ototoxicity, blood disorders, mental changes, myopathies and hepatic damage are not usually associated with malaria prophylaxis or treatment.",
                "html": "<p>Serious skin reactions, ECG changes, visual effects, ototoxicity, blood disorders, mental changes, myopathies and hepatic damage are not usually associated with malaria prophylaxis or treatment.</p>"
            }
        ],
        "overdosageInformation": [
            {
                "type": "overdosageInformation",
                "textContent": "Chlorquine is very toxic in overdosage; overdosage is extremely hazardous and difficult to treat. Urgent advice from the National Poisons Information Service is essential. Life-threatening features include arrhythmias (which can have a very rapid onset) and convulsions (which can be intractable).",
                "html": "<p>Chlorquine is very toxic in overdosage; overdosage is extremely hazardous and difficult to treat. Urgent advice from the National Poisons Information Service is essential. Life-threatening features include arrhythmias (which can have a very rapid onset) and convulsions (which can be intractable).</p>"
            }
        ]
    },
    "pregnancy": {
        "generalInformation": [
            {
                "type": "generalInformation",
                "textContent": "Benefit of use in prophylaxis and treatment in malaria outweighs risk. For rheumatoid disease, it is not necessary to withdraw an antimalarial drug during pregnancy if the disease is well controlled.",
                "html": "<p>Benefit of use in prophylaxis and treatment in malaria outweighs risk. For rheumatoid disease, it is not necessary to withdraw an antimalarial drug during pregnancy if the disease is well controlled.</p>"
            }
        ]
    },
    "breastFeeding": {
        "generalInformation": [
            {
                "type": "generalInformation",
                "textContent": "Present in breast milk and breast-feeding should be avoided when used to treat rheumatic disease. Amount in milk probably too small to be harmful when used for malaria.",
                "html": "<p>Present in breast milk and breast-feeding should be avoided when used to treat rheumatic disease. Amount in milk probably too small to be harmful when used for malaria.</p>"
            }
        ]
    },
    "hepaticImpairment": {
        "generalInformation": [
            {
                "type": "generalInformation",
                "textContent": "Use with caution in moderate to severe impairment.",
                "html": "<p>Use with caution in moderate to severe impairment.</p>"
            }
        ]
    },
    "renalImpairment": {
        "doseAdjustments": [
            {
                "type": "doseAdjustments",
                "textContent": "Only partially excreted by the kidneys and reduction of the dose is not required for prophylaxis of malaria except in severe impairment.\n\nFor rheumatoid arthritis and lupus erythematosus, reduce dose.",
                "html": "<p>Only partially excreted by the kidneys and reduction of the dose is not required for prophylaxis of malaria except in severe impairment.</p><p>For rheumatoid arthritis and lupus erythematosus, reduce dose. </p>"
            }
        ],
        "generalInformation": [
            {
                "type": "generalInformation",
                "textContent": "Manufacturers advise caution.",
                "html": "<p>Manufacturers advise caution.</p>"
            }
        ]
    },
    "monitoringRequirements": {
        "patientParameters": [
            {
                "type": "patientParameters",
                "specificity": {
                    "textContent": "With oral use in adults",
                    "html": "With <ph outputclass=\"route\">oral</ph> use in adults",
                    "patientType": "adults",
                    "routes": [
                        "oral"
                    ]
                },
                "textContent": "Manufacturers recommend regular ophthalmological examination but the evidence of practical value is unsatisfactory.",
                "html": "<p>Manufacturers recommend regular ophthalmological examination but the evidence of practical value is unsatisfactory.</p>"
            },
            {
                "type": "patientParameters",
                "specificity": {
                    "textContent": "With oral use in children",
                    "html": "With <ph outputclass=\"route\">oral</ph> use in children",
                    "patientType": "children",
                    "routes": [
                        "oral"
                    ]
                },
                "textContent": "Ophthalmic examination with long-term therapy.",
                "html": "<p>Ophthalmic examination with long-term therapy.</p>"
            }
        ]
    },
    "patientAndCarerAdvice": {
        "generalPatientAdvice": [
            {
                "type": "generalPatientAdvice",
                "textContent": "Warn travellers going to malarious areas about importance of avoiding mosquito bites, importance of taking prophylaxis regularly, and importance of immediate visit to doctor if ill within 1 year and especially within 3 months of return.",
                "html": "<p>Warn travellers going to malarious areas about <b>importance</b> of avoiding mosquito bites, <b>importance</b> of taking prophylaxis regularly, and <b>importance</b> of immediate visit to doctor if ill within 1 year and <b>especially</b> within 3 months of return.</p>"
            }
        ]
    },
    "nationalFunding": {
        "nonNHS": [
            {
                "type": "nonNHS",
                "textContent": "Drugs for malaria prophylaxis not prescribable on the NHS; health authorities may investigate circumstances under which antimalarials are prescribed.",
                "html": "<p>Drugs for malaria prophylaxis not prescribable on the NHS; health authorities may investigate circumstances under which antimalarials are prescribed.</p>"
            }
        ]
    },
    "exceptionsToLegalCategory": {
        "exceptionsToLegalCategory": [
            {
                "type": "exceptionsToLegalCategory",
                "textContent": "Can be sold to the public provided it is licensed and labelled for the prophylaxis of malaria.",
                "html": "<p>Can be sold to the public provided it is licensed and labelled for the prophylaxis of malaria.</p>"
            }
        ]
    },
    "medicinalForms": {
        "licensingVariationStatement": [
            {
                "type": "licensingVariationStatement",
                "textContent": "There can be variation in the licensing of different medicines containing the same drug.",
                "html": "<p>There can be variation in the licensing of different medicines containing the same drug.</p>"
            }
        ]
    },
    "children": {
        "medicinalForm": [
            {
                "id": "PHP76546",
                "label": "Tablet",
                "type": "medicinalForm"
            },
            {
                "id": "PHP76551",
                "label": "Oral solution",
                "type": "medicinalForm"
            }
        ]
    },
    "backlinks": {
        "drug": [
            {
                "id": "PHP98624",
                "label": "CHLOROQUINE WITH PROGUANIL",
                "type": "drug"
            }
        ],
        "drugClassifications": [
            {
                "id": "PHP106980",
                "label": "Drug classifications",
                "type": "drugClassifications"
            }
        ],
        "treatmentSummary": [
            {
                "id": "PHP97237",
                "label": "Adverse reactions to drugs",
                "type": "treatmentSummary"
            },
            {
                "id": "PHP78098",
                "label": "Antimalarials",
                "type": "treatmentSummary"
            },
            {
                "id": "PHP78102",
                "label": "Malaria, prophylaxis",
                "type": "treatmentSummary"
            },
            {
                "id": "PHP78113",
                "label": "Malaria, treatment",
                "type": "treatmentSummary"
            },
            {
                "id": "PHP78421",
                "label": "Rheumatic disease, suppressing drugs",
                "type": "treatmentSummary"
            },
            {
                "id": "PHP78455",
                "label": "Corticosteroids, inflammatory disorders",
                "type": "treatmentSummary"
            },
            {
                "id": "PHP78614",
                "label": "Arthritis",
                "type": "treatmentSummary"
            }
        ]
    },
    "links": {
        "interaction": [
            {
                "id": "bnf_int_335",
                "label": "Chloroquine",
                "type": "interaction"
            }
        ],
        "treatmentSummary": [
            {
                "id": "PHP78608",
                "label": "Acute porphyrias",
                "type": "treatmentSummary"
            }
        ],
        "#drugs": [
            {
                "id": "drugs",
                "label": "Drugs",
                "type": "#drugs"
            }
        ],
        "medicinalForm": [
            {
                "id": "PHP76546",
                "label": "Tablet",
                "type": "medicinalForm"
            },
            {
                "id": "PHP76551",
                "label": "Oral solution",
                "type": "medicinalForm"
            }
        ]
    }
}